Xencor reported 29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AbbVie 23.96 0.93 Jun/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amgen 18.07 1.77 Jun/2026
Arrowhead Research 39.19 2.48 Mar/2026
AstraZeneca 25.34 4.25 Jun/2026
Biogen 23.23 9.53 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
J&J 29.43 4.9 Jun/2026
Merck 32.26 15.74 Jun/2026
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Xencor 29.92 3.22 Sep/2022